ABSTRACT
Binders of langerin could target vaccines to Langerhans cells for improved therapeutic effect. Since langerin has low affinity for monovalent glycan ligands, highly multivalent presentation has previously been key for targeting. Aiming to reduce the amount of ligand required, we rationally designed molecularly defined high-affinity binders based on the precise display of glycomimetic ligands (Glc2NTs) on DNA-PNA scaffolds. Rather than mimicking langerin's homotrimeric structure with a C3-symmetric scaffold, we developed readily accessible, easy-to-design bivalent binders. The method considers the requirements for bridging sugar binding sites and statistical rebinding as a means to both strengthen the interactions at single binding sites and amplify the avidity enhancement provided by chelation. This gave a 1150-fold net improvement over the affinity of the free ligand and provided a nanomolar binder (IC50 =300â nM) for specific internalization by langerin-expressing cells.
Subject(s)
Antigens, CD/chemistry , DNA/chemistry , Lectins, C-Type/chemistry , Mannose-Binding Lectins/chemistry , Binding Sites , Humans , Langerhans Cells/chemistry , Ligands , Models, Molecular , Molecular ConformationABSTRACT
Langerhans cell histiocytosis (LCH) is a rare histiocytic disorder characterized by clonal proliferation of neoplastic Langerhans cells (LCs). LC proliferation can also be seen in different reactive dermatosis. CyclinD1 is a downstream marker of mitogen-activated protein (MAP) kinase pathway, which is often activated in LCH. This study aimed to evaluate the role of cyclinD1 to differentiate reactive LC proliferation from LCH. All cases of cutaneous LCH diagnosed by biopsy in the past 3 years (n = 13) were immunostained with CD1a, p53, CD31, and cyclinD1. Seven cases each of discoid lupus erythematosus (DLE) and lichen planus (LP) were taken as control. Presence of p53, CD31, and cyclinD1-positive LCs (CD1a-positive) were compared in the dermis. In all LCH cases, dermal neoplastic LCs showed diffuse CD1a positivity and 12 cases (92.3%) showed variable (30%-70%) cyclinD1 expression. Weak p53 and CD31 expression were seen in 61.5% and 46.1% of LCH cases, respectively. In the control group, 5 cases of LP and 4 cases of DLE showed variable LC proliferation, highlighted by CD1a positivity. However, no case of reactive dermatosis showed cyclinD1 or p53 expression by the reactive LCs. Weak and patchy CD31 expression by the reactive LCs were found in 1 (25%) and 2 (40%) cases of DLE and LP, respectively. To conclude, cyclinD1 is frequently expressed in neoplastic LCs in LCH. It is an efficient marker to differentiate neoplastic from reactive LC proliferation, and can be used as a surrogate marker in LCH.
Subject(s)
Cell Proliferation , Cyclin D1/analysis , Histiocytosis, Langerhans-Cell/diagnosis , Immunohistochemistry , Langerhans Cells/chemistry , Skin/chemistry , Adolescent , Adult , Biomarkers/analysis , Case-Control Studies , Child , Child, Preschool , Diagnosis, Differential , Female , Histiocytosis, Langerhans-Cell/metabolism , Histiocytosis, Langerhans-Cell/pathology , Humans , Infant , Langerhans Cells/pathology , Male , Predictive Value of Tests , Skin/pathology , Young AdultABSTRACT
Langerhans cell (LC) histiocytoma is a neonatal tumor that often consists of a single, ulcerated nodule. Systemic involvement is rare, and LC histiocytoma is considered to be a variant of congenital, self-healing LC histiocytosis (also referred to as Hashimoto-Pritzker disease). In view of its low prevalence, LC histiocytoma is not always diagnosed in a clinical examination and requires histological confirmation. Furthermore, the histological and molecular features of LC histiocytoma have not been well characterized. Here, we report on 6 cases of this rare disease and review the corresponding literature. LC histiocytoma differs from classical self-healing LC histiocytosis with regard to the pathological features; we found that LC histiocytoma was associated with massive infiltration by histiocytes of various sizes and shapes (although often large) throughout the dermis and the superficial subcutis. Epidermotropism was rare, mitotic figures were not inconspicuous, and necrotic or calcified areas were often present. Immunohistochemical assessment revealed a mixture of different types of histiocytes (with CD1a CD207, CD1a CD207, and CD1a CD207 CD163 cells). Genetic testing was performed in 5 cases; it revealed a BRAF mutation (p.V600E and p.485_490delinsF) in 2 cases, a HRAS mutation (p.T58I) in 1 case, a combination of 2 PTEN mutations in another case (p.I224M and p. R234W), and no mutations in the fifth case. All the lesions regressed spontaneously, and none recurred during follow-up.
Subject(s)
Histiocytes/pathology , Histiocytoma, Benign Fibrous/pathology , Histiocytosis, Langerhans-Cell/pathology , Langerhans Cells/pathology , Skin Neoplasms/pathology , Biomarkers, Tumor/analysis , Biomarkers, Tumor/genetics , Female , Genetic Predisposition to Disease , Histiocytes/chemistry , Histiocytoma, Benign Fibrous/chemistry , Histiocytoma, Benign Fibrous/genetics , Histiocytosis, Langerhans-Cell/genetics , Histiocytosis, Langerhans-Cell/metabolism , Humans , Infant , Infant, Newborn , Langerhans Cells/chemistry , Male , Mutation , Neoplasm Regression, Spontaneous , Phenotype , Skin Neoplasms/chemistry , Skin Neoplasms/geneticsABSTRACT
CLINICAL CASE: A 10-year-old girl was seen with a 3-week history of right upper lid swelling and with no other symptoms or fever. There was no recent history of sinusitis, trauma, or previous infection involving the periorbital area, or response to oral antibiotic treatment. Orbital computed tomography showed a lesion involving the upper margin of the orbit, and bone destruction at the orbital roof. Biopsy performed revealed the presence of Langerhans cell Histiocytosis. The lesion was surgically debulked and corticosteroids were used intra-operatively. The lesion responded to treatment. DISCUSSION: The orbital involvement of Langerhans cell histiocytosis, despite its low incidence, should be considered in the examination of acute peri-orbital swelling. It usually presents as an osteolytic lesion, and it is confirmed with a histological examination and immunohistochemical techniques for CD1a and S100. An interdisciplinary approach is recommended to rule out multifocal or multisystemic diseases, as well as to develop an appropriate treatment strategy.
Subject(s)
Histiocytosis, Langerhans-Cell/diagnosis , Orbital Cellulitis/etiology , Antigens, CD1/analysis , Biomarkers , Child , Cytoreduction Surgical Procedures , Female , Histiocytosis, Langerhans-Cell/complications , Histiocytosis, Langerhans-Cell/diagnostic imaging , Histiocytosis, Langerhans-Cell/therapy , Humans , Langerhans Cells/chemistry , Orbital Cellulitis/diagnostic imaging , Orbital Cellulitis/drug therapy , Orbital Cellulitis/surgery , Osteolysis/etiology , S100 Proteins/analysis , Tomography, X-Ray Computed , Treatment Outcome , Triamcinolone/therapeutic useABSTRACT
Giant Mudskipper, Periophthalmodon schlosseri (Pallas, 1770), is euryhaline, amphibious, and air-breathing fish. These fishes live in close association to mangrove forests and often spend over 90% of time out of water, in adjacent mudflats. They have developed morphological and physiological adaptations to satisfy their unique lifestyles. The skin is the primary interface between the body and the environment, and has a central role in host defence. The initiation of immune responses to antigens in the vertebrate skin has often been attributed to epidermal Langerhans'cells (LC) that are dendritic cells (DC), antigen-presenting cells (APC) which reside in the epidermis. Dendritic cells have been characterized morphologically and functionally in the teleost fish tissues such as rainbow trout, salmonids, medaka, African catfish and zebrafish. However, there is no evidence of the presence of DCs and their role in mudskippers immunity. The aim of this preliminary study was to characterize, through use of specific antibodies: Toll-like receptor 2, S100, serotonin (5-HT), and Vesicular acetylcholine transporter VAChT, a specific DC-like subpopulation in Pn. schlosseri's epidermis.
Subject(s)
Fish Proteins/metabolism , Langerhans Cells/chemistry , Perciformes/physiology , Animals , Immunohistochemistry/veterinary , S100 Proteins/metabolism , Serotonin/metabolism , Toll-Like Receptor 2/metabolism , Vesicular Acetylcholine Transport Proteins/metabolismABSTRACT
OBJECTIVE: Langerhans cell histiocytosis (LCH) is an uncommon neoplasm of dendritic cells and predominantly occurs in children and young adults. The study aims to evaluate cytopathologic features and current diagnostic concepts in a large series of LCH on fine needle aspiration (FNA). STUDY DESIGN: We retrospectively searched the pathology archives of The Johns Hopkins Hospital (JHH) and Emory University Hospital (EUH) to identify all FNA cases diagnosed as LCH in a period of 21 years. Cytologic material and immunohistochemical stains were reviewed. RESULTS: A total of 37 LCH patients (26 from JHH and 11 from EUH) with FNA diagnoses were identified. The sites of LCH included bone in 28, soft tissue of head and neck in 6, and lymph nodes in 3. Thirty-one patients (84%) were diagnosed as LCH, 4 (11%) had a descriptive diagnosis suggesting scant cellularity with epithelioid/histiocyte-like cells and mixed inflammation, and 2 (5%) were non-diagnostic due to insufficient cellularity. Immunohistochemical stains were performed on cell block sections in 26 cases, showing 24 of 24 (100%) positive for CD1a, 22 of 23 (96%) positive for S100-protein, and 3 of 3 (100%) positive for CD68. CONCLUSIONS: LCH can be accurately diagnosed in FNA based on the characteristic cytomorphology and selected immunohistochemistry. Diagnosis may be difficult in cases with scant or insufficient cellular material.
Subject(s)
Biopsy, Fine-Needle , Histiocytosis, Langerhans-Cell/diagnosis , Langerhans Cells/pathology , Adolescent , Adult , Antigens, CD1/analysis , Baltimore , Biomarkers/analysis , Child , Child, Preschool , Diagnosis, Differential , Female , Georgia , Histiocytosis, Langerhans-Cell/metabolism , Histiocytosis, Langerhans-Cell/pathology , Humans , Immunohistochemistry , Infant , Langerhans Cells/chemistry , Male , Middle Aged , Predictive Value of Tests , Reproducibility of Results , Retrospective Studies , S100 Proteins/analysis , Young AdultABSTRACT
Pellagra is a nutrient deficiency disease caused by insufficient niacin levels. Recent studies have shown that numbers of epidermal Langerhans cells decreased in other diseases caused by nutritional deficiencies, including necrolytic migratory erythema and acrodermatitis enteropathica. Epidermal Langerhans cells are capable of modulating or even halting the inflammatory reaction. The aim of this study was to examine changes in the number of Langerhans cells and other dendritic cells, and maturation of epidermal Langerhans cells in the lesional and adjacent non-lesional skin in pellagra patients. Seven pellagra patients and 10 healthy individuals who served as controls were included. The number and distribution of dendritic cells and other cutaneous cells were examined by immunohistochemistry. Epidermal Langerhans cells decreased considerably in the skin lesions of pellagra patients, whereas other dendritic cells did not change. The decrease in the number of Langerhans cells was positively correlated with the histological severity of skin lesions. As the number of Langerhans cells was not reduced in the undisturbed neighboring skin, the depletion of epidermal Langerhans cells did not precede skin damage but was a cause of prolonged severe inflammation.
Subject(s)
Epidermis/pathology , Langerhans Cells/pathology , Pellagra/pathology , Adult , Aged , Biopsy , Case-Control Studies , Cell Count , Epidermis/chemistry , Female , Humans , Immunohistochemistry , Japan , Langerhans Cells/chemistry , Male , Middle Aged , Severity of Illness IndexSubject(s)
Biomarkers, Tumor/analysis , Interleukin-12 Subunit p35/analysis , Mycosis Fungoides/diagnosis , Skin Neoplasms/diagnosis , Dendritic Cells/chemistry , Dermis/pathology , Eczema/pathology , Female , Humans , Infant , Langerhans Cells/chemistry , Male , Middle Aged , Mycosis Fungoides/chemistry , Mycosis Fungoides/pathology , Psoriasis/pathology , Skin Neoplasms/chemistry , Skin Neoplasms/pathology , Tumor MicroenvironmentABSTRACT
The cellular microenvironment has been proven to play a crucial role in solid tumours and seems to be important in haematologic malignancies, however, it has not been adequately investigated in primary cutaneous T cell lymphomas. The aim of this study was to register the composition of the cellular microenvironment in mycosis fungoides skin lesions and correlate the composing parameters with the clinical data and follow-up results. The presence of eosinophilic polymorphonuclear leukocytes, B lymphocytes, CD68+ macrophages, and CD1a+ epidermal Langerhans and antigen-presenting dermal dendritic cells, as well as their relation to clinicopathological parameters, were studied in 16 mycosis fungoides cases of different disease stages. The presence and nature of the participating T cell populations was also investigated. CD8+ tumour infiltrating T cells and CD56+ cells were found among neoplastic CD4+ T cells in the lesions. Generally, eosinophils and B lymphocytes were absent or in low numbers, regardless of clinical presentation, contrary to tumourous lesions. Macrophages and CD1a+ cells were constantly present, even in early-stage mycosis fungoides. The reduced presence of the CD1a+ population was associated with resistance to therapy (x2; p = 0.012). There is a striking difference in cellular microenvironment composition between early and advanced mycosis fungoides lesions.
Subject(s)
Mycosis Fungoides/immunology , Mycosis Fungoides/pathology , Skin Neoplasms/immunology , Skin Neoplasms/pathology , Tumor Microenvironment/immunology , Adult , Aged , Antigens, CD/analysis , Antigens, CD1/analysis , Antigens, Differentiation, Myelomonocytic/analysis , B-Lymphocytes , CD8-Positive T-Lymphocytes , Dermis/immunology , Dermis/pathology , Eosinophils , Epidermis/immunology , Epidermis/pathology , Female , Humans , Immunohistochemistry , Langerhans Cells/chemistry , Lymphocyte Count , Lymphocytes, Tumor-Infiltrating , Macrophages/chemistry , Male , Middle Aged , Neoplasm Staging , NeutrophilsSubject(s)
Histiocytosis, Langerhans-Cell/diagnosis , Hemianopsia/etiology , Histiocytosis, Langerhans-Cell/complications , Histiocytosis, Langerhans-Cell/radiotherapy , Humans , Hypopituitarism/etiology , Hypopituitarism/radiotherapy , Langerhans Cells/chemistry , Lymphatic Diseases/etiology , Male , Parotitis/etiology , Proctitis/etiology , Young AdultABSTRACT
BACKGROUND: Jorge Lobo's disease (JLD) is a cutaneous chronic mycosis caused by Lacazia loboi. We studied Factor XIIIa + dermal dendrocytes (FXIIIa + DD), Langerhans cells (LC) through the expression of langerin and the expression of S100 protein. METHODS: A total of 41 biopsies and 10 normal skins (control) were developed with a polymer-based immunohistochemical method. RESULTS: Lesions presented infiltrate comprising macrophages, some asteroid corpuscles, lymphocytes, multinucleated giant cells and a large number of fungi. LCs presented short dendrites and were scarcely distributed. Dermal langerin + cells were detected in nine JLD lesions. FXIIIa + DD were hypertrophic, visualized in the inflammatory infiltrate of JLD lesions. Cells S100+ were present in JLD and control group with a similar number of cells. A total of 14 specimens did not express FXIIIa, and this considerable number probably contributed to the statistical similarity with the control group. CONCLUSIONS: The results indicate that LCs are present in the immune response against Lacazia loboi. Some dermal langerin + cells could be another subset of dendritic cells. Our data indicate changes of LCs in JLD cutaneous lesions and present, for the first time, results that show langerin + cells in the dermis and corroborate previous observations on the participation of FXIIIa + DD in the in situ immune response in JLD.
Subject(s)
Langerhans Cells/immunology , Lobomycosis/pathology , Antigens, CD/immunology , Humans , Immunohistochemistry , Lacazia/isolation & purification , Lacazia/physiology , Langerhans Cells/chemistry , Lectins, C-Type/immunology , Lobomycosis/immunology , Mannose-Binding Lectins/immunology , S100 Proteins/immunology , Skin/chemistry , Skin/immunology , Skin/pathology , Staining and LabelingABSTRACT
BACKGROUND: Meyerson's phenomenon is characterized by a symmetrical halo of erythema and scale around central, mostly melanocytic lesions. OBJECTIVE: Our aim was to describe the dermoscopic and reflectance confocal microscopy (RCM) features of melanocytic tumors less frequently associated with Meyerson's phenomenon, with histopathology and immunohistochemistry correlation. METHODS: Clinical, dermoscopic and RCM images of 4 histopathologically confirmed melanocytic tumors associated with Meyerson's phenomenon (3 dysplastic compound nevi and 1 melanoma) were retrospectively collected, with additional immunohistochemical analysis. RESULTS: RCM showed in vivo features of both melanocytic and spongiotic nature of the lesion associated with Meyerson's phenomenon, even in cases with absent halo. Our study also supported the involvement of immune-mediated CD4+ T lymphocyte mechanisms and Langerhans cells. CONCLUSION: Our case series supports the potential of RCM in the evaluation of tumoral and inflammatory skin diseases. RCM features of rare Meyerson's melanoma were also described for the first time. © 2014 S. Karger AG, Basel.
Subject(s)
Langerhans Cells/chemistry , Lymphocytes/chemistry , Melanoma/pathology , Nevus, Pigmented/pathology , Skin Neoplasms/pathology , Aged , Antigens, CD1/analysis , Antigens, CD20/analysis , CD3 Complex/analysis , CD4 Lymphocyte Count , CD4-Positive T-Lymphocytes , CD8-Positive T-Lymphocytes , Dermoscopy , Female , Humans , Immunohistochemistry , Male , Melanoma/immunology , Microscopy, Confocal , Middle Aged , Nevus, Pigmented/immunology , Skin Neoplasms/immunology , Young AdultABSTRACT
Ectopic micronodular thymoma (MNT) is a rare tumor. We described a 76-year-old woman, who was referred to our institutional for a mass in the left cervical region. The Magnetic Resonance Imaging (MRI) scan showed a 3.7 cm × 1.7 cm × 2.0 cm mass. The neoplasm was composed of epithelial tumor cells arranged in a micronodular growth pattern set in a stroma showing lymphoid hyperplasia with germinal centers. Immunohistochemical studies showed that the neoplastic epithelial cells were reactive for AE1/AE3, CK5/6, P63, and the lymphoid component to be of mixed B- and immature T-cell lineage. Langerhans cells were confirmed within epithelial nodules for the first time with langerin, S-100, CD1a expression. We report a case of cervical ectopic MNT to emphasize the langerhans cells proliferation and the histopathologic features and differential diagnosis of the rare lesion to promote a better and broader understanding of this less understood subject.
Subject(s)
Cell Proliferation , Choristoma/pathology , Langerhans Cells/pathology , Lymphocytes/pathology , Stromal Cells/pathology , Thymoma/pathology , Thyroid Gland , Thyroid Neoplasms/pathology , Aged , Biomarkers, Tumor/analysis , Biopsy , Choristoma/immunology , Choristoma/surgery , Female , Humans , Immunohistochemistry , Langerhans Cells/chemistry , Langerhans Cells/immunology , Lymphocytes/chemistry , Lymphocytes/immunology , Magnetic Resonance Imaging , Predictive Value of Tests , Stromal Cells/chemistry , Stromal Cells/immunology , Thymoma/chemistry , Thymoma/immunology , Thymoma/surgery , Thyroid Neoplasms/chemistry , Thyroid Neoplasms/immunology , Thyroid Neoplasms/surgery , Treatment Outcome , Tumor BurdenABSTRACT
BACKGROUND: Chronic alcoholism is associated with increased incidence and severity of skin infection. Cutaneous dendritic cells (CDCs) play a pivotal role in skin immunity, and chronic ethanol (EtOH) feeding in mice has been shown to inhibit CDC migration to skin-draining lymph nodes (dLNs) following epicutaneous sensitization. Because CDC subsets differentially initiate T-cell responses, it is important to determine how EtOH feeding affects migration of each subset and identify mechanisms responsible for observed defects. METHODS: Mice received EtOH in the drinking water for ≥ 16 weeks. Baseline numbers of CDC subsets and their migration to the dLNs following fluorescein 5-isothiocyanate (FITC) sensitization were assessed by flow cytometry. Epidermal cell suspension and skin explant cultures were used to measure the impact of EtOH upon molecules that influence CDC migration. Cytokine arrays performed on explant culture supernatants assessed local production of inflammatory cytokines. RESULTS: Chronic EtOH feeding reduced migration of all CDC subsets to the dLNs following FITC sensitization. Reduced migration of dermal-resident CDCs did not correspond with reduced baseline numbers of these cells. For Langerhans cells (LCs), EtOH-induced migratory dysfunction corresponded with delayed down-regulation of E-cadherin, chemokine receptor 1 (CCR1), and CCR6 and impaired up-regulation of matrix metalloproteinases (MMPs) 2 and 9. In skin explant assays, EtOH blunted CDC mobilization following stimulation with CCL21/CPG 1826. No alteration in CD54 or CCR7 expression was observed, but production of skin-derived tumor necrosis factor alpha (TNF-α) was reduced. Poor migratory responses in vitro could be improved by supplementing explant cultures from EtOH-fed mice with TNF-α. CONCLUSIONS: Chronic EtOH consumption does not alter baseline dermal-resident CDC numbers. However, like LCs, migratory responsiveness of dermal CDCs was decreased following FITC sensitization. Inefficient down-regulation of both CCRs and adhesion molecules and the inability to up-regulate MMPs indicate that EtOH impedes LC acquisition of a promigratory phenotype. These defects, combined with improvement of the migratory defect with in vitro TNF-α replacement, demonstrate intrinsic as well as environmental contributions to defective CDC migration. These findings provide novel mechanisms to explain the observed increased incidence and severity of skin infections in chronic alcoholics.
Subject(s)
Ethanol/administration & dosage , Langerhans Cells/drug effects , Langerhans Cells/physiology , Animals , Cell Movement/drug effects , Cells, Cultured , Cytokines/analysis , Female , Gene Expression/drug effects , Intercellular Adhesion Molecule-1/genetics , Langerhans Cells/chemistry , Matrix Metalloproteinases/genetics , Mice , Mice, Inbred C57BL , Receptors, CCR7/genetics , Tumor Necrosis Factor-alpha/pharmacologyABSTRACT
Spiradenoma is unique with respect to the presence of a large number of non-epithelial cells, including S100 protein(+) cells, most of which are presumably Langerhans cells, in the parenchyma as shown in the published work. However, the characterization of these non-epithelial cells to date is insufficient. Immunohistochemistry of CD1a, CD3, CD4, CD8, CD56, CD68, intercellular adhesion molecule-1 (ICAM-1), and HLA-DR, as well as double-immunofluorescence labeling of S100 protein/CD1a and CD1a/CD3, was performed using paraffin-embedded specimens from five cases of spiradenoma retrospectively. Non-epithelial cells evenly distributed throughout the parenchyma of spiradenoma primarily consisted of CD1a(+) Langerhans cells and CD3(+) T cells. ICAM-1 was expressed by epithelial cells and non-epithelial cells in the parenchyma. HLA-DR on the epithelial cells was limited to the focal area. In double-immunofluorescence labeling, approximately one-half of Langerhans cells were spatially related to T cells in the parenchyma, suggesting their functional interaction.
Subject(s)
Adenoma/pathology , Langerhans Cells/pathology , Skin Neoplasms/pathology , T-Lymphocytes/pathology , Adenoma/immunology , Adult , Aged , Antigens, CD1/analysis , Female , Humans , Immunohistochemistry , Langerhans Cells/chemistry , Male , Middle Aged , Retrospective Studies , Skin/immunology , Skin/pathology , Skin Neoplasms/immunologyABSTRACT
OBJECTIVE: To study the clinico-pathological characteristics of Langerhans cell sarcoma (LCS) which involving epidermis. METHODS: A case of primary multifocal LCS was analyzed in histopathology and immunophenotype. RESULTS: A 41-year-old man with multifocal cutaneous LCS involving the inguina and waist was reported. Clinical and pathology data were available. Neoplastic cells with markedly malignant cytological features were observed. Tumor cells exhibited irregular shape with abundant and eosinophilic red staining cytoplasm; large, irregular-shaped, showing lobulated or dented nucleus and some cells with a longitudinal nuclear groove and prominent nucleoli. The tumor cells expressed CD1a, Langerin (CD207), S-100 protein, CD68 and vimentin, and did not express pan-T or B cell markers and epithelial markers. The patient died less than 1 year after diagnosis due to local recurrence and metastasis to the lung, despite the administration of local radiation and chemotherapy. CONCLUSIONS: LCS is a tumor with markedly malignant cytological features that originates from Langerhans cells. Primary multifocal neoplasms involving epidermis is even rare. Accurate diagnosis is based on the histopathological and immunohistochemical of the tumor cells. VIRTUAL SLIDE: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1182345104754765.
Subject(s)
Epidermis/pathology , Langerhans Cell Sarcoma/pathology , Langerhans Cells/pathology , Skin Neoplasms/pathology , Adult , Biomarkers, Tumor/analysis , Biopsy , Epidermis/chemistry , Epidermis/immunology , Fatal Outcome , Humans , Immunophenotyping , Langerhans Cell Sarcoma/immunology , Langerhans Cell Sarcoma/therapy , Langerhans Cells/chemistry , Langerhans Cells/immunology , Lung Neoplasms/secondary , Male , Neoplasm Recurrence, Local , Skin Neoplasms/chemistry , Skin Neoplasms/immunology , Skin Neoplasms/therapy , Time Factors , Treatment OutcomeABSTRACT
Since the 7th amendment to the EU cosmetics directive foresees a complete ban on animal testing, alternative in vitro methods have been established to evaluate the sensitizing potential of small molecular weight compounds. To find out whether these novel in vitro assays are also capable to predict the sensitizing potential of small molecular weight drugs, model compounds such as beta-lactams and sulfonamides - which are the most frequent cause of adverse drug reactions - were co-incubated with THP-1, MUTZ-LC, or primary monocyte-derived dendritic cells for 48 h and subsequent expression of selected marker genes (IL-8, IL-1ß, CES1, NQO1, GCLM, PIR and TRIM16) was studied by real time PCR. Benzylpenicillin and phenoxymethylpenicillin were recognized as sensitizing compounds because they are capable to induce the mRNA expression of these genes in moDCs and, except for IL-8, in THP-1 cells but not in MUTZ-LC. Ampicillin stimulated the expression of some marker genes in moDCs and THP-1 cells. SMX did not affect the expression of these genes in THP-1, however, in moDCs, at least PIR was enhanced and there was an increase of the release of IL-8. These data reveal that novel in vitro DC based assays might play a role in the evaluation of the allergenic potential of novel drug compounds, but these systems seem to lack the ability to detect the sensitizing potential of prohaptens that require metabolic activation prior to sensitization and moDCs seem to be superior with regard to the sensitivity compared with THP-1 and MUTZ-3 cell lines.
Subject(s)
Anti-Bacterial Agents/pharmacology , Dendritic Cells/drug effects , Langerhans Cells/drug effects , Macrophages/drug effects , Monocytes/drug effects , Ampicillin/adverse effects , Ampicillin/pharmacology , Anti-Bacterial Agents/adverse effects , Carboxylic Ester Hydrolases/analysis , Carcinoma, Renal Cell/chemistry , Carcinoma, Renal Cell/metabolism , Carrier Proteins/analysis , Cell Line , Cell Line, Tumor , DNA-Binding Proteins/analysis , Dendritic Cells/chemistry , Dioxygenases , Glutamate-Cysteine Ligase/analysis , Humans , In Vitro Techniques , Interleukin-1beta/analysis , Interleukin-8/analysis , Langerhans Cells/chemistry , Macrophages/chemistry , Monocytes/chemistry , NAD(P)H Dehydrogenase (Quinone)/analysis , Nuclear Proteins/analysis , Penicillin G/adverse effects , Penicillin G/pharmacology , Penicillin V/adverse effects , Penicillin V/pharmacology , Real-Time Polymerase Chain Reaction , Sulfamethoxazole/adverse effects , Sulfamethoxazole/pharmacology , Transcription Factors/analysis , Tripartite Motif Proteins , Ubiquitin-Protein LigasesABSTRACT
To increase (tumor) vaccine efficacy, there is an urgent need for phenotypic and functional characterization of human dendritic cell (DC) subsets residing in lymphoid tissues. In this study we identified and functionally tested 4 human conventional DC (cDC) subsets within skin-draining sentinel lymph nodes (SLNs) from early-stage melanoma patients. These SLNs were all tumor negative and were removed on average 44 days after excision of the primary melanoma. As such, they were considered representative of steady-state conditions. On comparison with skin-migrated cDC, 2 CD1a(+) subsets were identified as most likely skin-derived CD11c(int) Langerhans cells (LC) with intracellular langerin and E-cadherin expression or as CD11c(hi) dermal DCs with variable expression of langerin. Two other CD1a(-) LN-residing cDC subsets were characterized as CD14(-)BDCA3(hi)CD103(-) and CD14(+)BDCA3(lo)CD103(+), respectively. Whereas the CD1a(+) skin-derived subsets displayed greater levels of phenotypic maturation, they were associated with lower levels of inflammatory cytokine release and were inferior in terms of allogeneic T-cell priming and IFNγ induction. Thus, despite their higher maturation state, skin-derived cDCs (and LCs in particular) proved inferior T-cell activators compared with the CD1a(-) cDC subsets residing in melanoma-draining LNs. These observations should be considered in the design of DC-targeting immunotherapies.
Subject(s)
Dendritic Cells/classification , Langerhans Cells/immunology , Lymph Nodes/cytology , Lymphocyte Activation , Skin/immunology , T-Lymphocytes/immunology , Antigens, CD/analysis , Antigens, CD1/analysis , Antigens, Surface/analysis , CD11c Antigen/analysis , Cadherins/analysis , Dendritic Cells/chemistry , Dendritic Cells/immunology , Flow Cytometry , Humans , Immunophenotyping , Integrin alpha Chains/analysis , Langerhans Cells/chemistry , Lectins, C-Type/analysis , Lipopolysaccharide Receptors/analysis , Lymph Nodes/immunology , Lymphocyte Culture Test, Mixed , Lymphokines/metabolism , Mannose-Binding Lectins/analysis , Melanoma/immunology , Melanoma/pathology , Melanoma/surgery , Sentinel Lymph Node Biopsy , Skin Neoplasms/immunology , Skin Neoplasms/pathology , Skin Neoplasms/surgery , ThrombomodulinABSTRACT
We studied the morphology and occurrence of splenic Langerhans-like (LL) cells in species representing 11 orders of ray-finned fishes, Actinopterygii. LL cells were frequent in spleen tissue of species among Cypriniformes, Esociformes, Salmoniformes, and Pleuronectiformes. These cells contained granules which resembled Birbeck granules known to occur in mammalian Langerhans cells. The ultrastructure of LL cells in Northern pike, Esox lucius, and in Atlantic halibut, Hippoglossus hippoglossus were similar to those reported in salmonids. LL cells found in cyprinids shared some characteristics with the LL cells in other Actinopterygii species, although unique structures distinguished them from the latter. They contained dense bodies within the Birbeck-like (BL) granules, a characteristic that was never observed in species outside the Cypriniformes. Two types of BL granules were characterized in cyprinid LL cells. The ultrastructure of BL granules across the species is discussed. LL cells in all Actinopterygii species demonstrated close contacts with nearby cells, characterized by adherens-like junctions. Additionally, multivesicular bodies were present within the cytoplasm and large aggregates of exosomes were observed closely associated with the plasma membrane suggesting their release from the cells. These structures are discussed in relation to mammalian dendritic cells. Macrophages found in European perch, Perca fluviatilis, blue gourami, Trichogaster trichopterus, and Atlantic halibut, Hippoglossus hippoglossus contained lysosomes and residual bodies with structures resembling Birbeck granules. These granules and cells were clearly distinct from LL cells.
Subject(s)
Fishes/anatomy & histology , Langerhans Cells/ultrastructure , Spleen/cytology , Animals , Cytoplasmic Granules/ultrastructure , Langerhans Cells/chemistry , Microscopy, Electron, Transmission , Multivesicular Bodies/ultrastructure , Spleen/ultrastructureABSTRACT
BACKGROUND: Sublingual immunotherapy (SLIT) is safe and reduces both symptoms and medication requirements in patients with type I respiratory allergies. Nonetheless, immune mechanisms underlying SLIT need to be further documented. OBJECTIVE: A detailed characterization of the lingual immune system was undertaken in mice, to investigate the presence of tolerogenic and pro-inflammatory mechanisms. METHODS: Immune cells were characterized in lingual tissues from BALB/c mice using immunohistology and flow cytometry. Resident CD4(+) T cells were sorted and toll-like receptor (TLR) expression profiles as well as functional characterization were assessed by RT-PCR, T cell suppressive assays and cytokine gene expression, respectively. RESULTS: Eosinophils and mast cells were only detected in submucosal tissues. No NK, NK-T, gamma/delta, CD8(+) T cells, nor B-lymphocytes were detected. Potential antigen presenting cells include various subsets of dendritic cells (CD207(+) Langerhans cells, CD11b(+)CD11c(+) myeloid cells and 120G8(+) plasmacytoid DCs) together with F4/80(+) macrophages. Noteworthy, both CD103(-) and CD103(+) CD4(+) T cells expressing TLR2 and TLR4 receptors are present along the lamina propria, in vicinity of myeloid CD11b(+)CD11c(+/-) dendritic cells. Such resident lingual CD4(+) T lymphocytes comprise both suppressive T cells as well as cells with memory/effector functions (i.e. expressing IFN gamma, IL4, IL10 and IL17 genes following stimulation), irrespective of the presence of the mucosal addressing marker CD103. CONCLUSION: The sublingual route is pertinent to induce antigen-specific tolerance, due to (i) limited numbers of pro-inflammatory cells, rather located in submucosal tissues, (ii) co-localization of APCs and resident CD4(+) T cells with regulatory functions. Since the oral immune system can also elicit pro-inflammatory effector responses, the cytokine milieu in which allergens are presented by sublingual APCs needs to be controlled during immunotherapy (e.g. with adjuvants) in order to favour tolerance over inflammation.